Aditx Therapeutics Competitors and Similar CompaniesClear all

Aditx Therapeutics's competitors and similar companies include Laurus Bio, Abcam, Ephicacy and BioLegend.

	Aditx Therapeutics Aditx Therapeutics is a company that aims to develop DNA-based technologies to minimize the rejection of transplanted organs in humans.	Laurus Bio Laurus Bio (formerly Richcore Lifesciences) is an integrated research-driven biomanufacturing organization.	Abcam Abcam is a life sciences company that identifies and develops biological, protein, and custom cell engineering tools.	Ephicacy Ephicacy is a provider of consulting services and functional sourcing for the life sciences industry.	BioLegend BioLegend is a company that develops and manufactures antibodies and reagents.
Founding Date	Founding Date 2017	Founding Date 2005	Founding Date 1998	Founding Date 2005	Founding Date 2002
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech life sciences	Tags Healthcare biotech life sciences	Tags Healthcare biotech life sciences	Tags Healthcare biotech life sciences	Tags Healthcare biotech drug development
Locations	Locations Mountain View, US HQ	Locations Bengaluru, IN HQ Bengaluru, IN	Locations Cambridge, GB HQ Hangzhou Shi, CN Shanghai, CN Hong Kong, HK Tokyo, JP Branford, US Burlingame, US see more	Locations Woodbridge Township, US HQ Bengaluru, IN	Locations San Diego, US HQ Beijing, CN Tokyo, JP
Employees	Employees 2	Employees 410	Employees 6355% decrease	Employees 4301% decrease	Employees 6571% decrease
Financial
Revenue (est.)	Revenue (est.) $3.2k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) £236m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $2.9k (FY, 2025)	Cost of goods N/A	Cost of goods £116.9m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $268 (FY, 2025)	Gross profit N/A	Gross profit £119.1m (FY, 2024)	Gross profit N/A	Gross profit N/A